These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6132312)

  • 21. Ephedrine: effects on neuromuscular transmission.
    Sieb JP; Engel AG
    Brain Res; 1993 Sep; 623(1):167-71. PubMed ID: 8221087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maitotoxin activates quantal transmitter release at the neuromuscular junction: evidence for elevated intraterminal Ca2+ in the motor nerve terminal.
    Kim YI; Login IS; Yasumoto T
    Brain Res; 1985 Nov; 346(2):357-62. PubMed ID: 2996708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of blockade of neuromuscular transmission by pentobarbital.
    Seyama I; Narahashi T
    J Pharmacol Exp Ther; 1975 Jan; 192(1):95-104. PubMed ID: 164531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiamine blockade of neuromuscular transmission.
    Enomoto K; Edwards C
    Brain Res; 1985 Dec; 358(1-2):316-23. PubMed ID: 2416387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of perhydrohistrionicotoxin on neurally and iontophoretically evoked endplate currents.
    Albuquerque EX; Gage PW
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1596-9. PubMed ID: 206910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression of synaptic transmission by diphenylhydantoin.
    Yaari Y; Pincus JH; Argov Z
    Ann Neurol; 1977 Apr; 1(4):334-8. PubMed ID: 31132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Org. 6368: a nondepolarizing neuromuscular blocking agent with a novel effect on end-plate conductance.
    Durant NN; Horn R
    J Pharmacol Exp Ther; 1984 Mar; 228(3):567-72. PubMed ID: 6608583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lophotoxin irreversibly inactivates the nicotinic acetylcholine receptor by preferential association at one of the two primary agonist sites.
    Culver P; Fenical W; Taylor P
    J Biol Chem; 1984 Mar; 259(6):3763-70. PubMed ID: 6142893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The continual administration of neostigmine and the neuromuscular junction.
    Gillies JD; Allen J
    Proc Aust Assoc Neurol; 1976; 13():149-53. PubMed ID: 1029001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular defect after suppression of ion conductance.
    Takamori M; Ide Y; Kasai M
    Neurology; 1979 Jun; 29(6):772-9. PubMed ID: 221854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The timing of channel opening during miniature end-plate currents.
    Cohen I; van der Kloot W; Attwell D
    Brain Res; 1981 Oct; 223(1):185-9. PubMed ID: 6974583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction.
    Sellin LC; Thesleff S
    J Physiol; 1981 Aug; 317():487-95. PubMed ID: 6273549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of indomethacin on quantal acetylcholine release at the frog neuromuscular junction.
    Madden KS; van der Kloot W
    Adv Prostaglandin Thromboxane Res; 1980; 8():1273-5. PubMed ID: 6246778
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of etimizol on the neuromuscular synapse of the frog].
    Drabkina TM; Dobretsov MG
    Neirofiziologiia; 1985; 17(6):757-63. PubMed ID: 3003594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of serotonin (5-hydroxytryptamine) on amphibian neuromuscular junction.
    Akasu T; Karczmar AG; Koketsu K
    Eur J Pharmacol; 1983 Mar; 88(1):63-70. PubMed ID: 6602056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between quantal secretion and vesicle loss at the frog neuromuscular junction.
    Hurlbut WP; Iezzi N; Fesce R; Ceccarelli B
    J Physiol; 1990 Jun; 425():501-26. PubMed ID: 2120425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of emetine and dehydroemetine at the frog neuromuscular junction.
    Alkadhi KA
    Eur J Pharmacol; 1987 Jun; 138(2):257-64. PubMed ID: 2887439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.